The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
Open accessAbstract
Mycosis fungoides (MF) and Sézary syndrome (SS), the major forms of cutaneous T-cell lymphoma, have unique characteristics that distinguish them from other types of non-Hodgkin's lymphomas. Clinical trials in MF/SS have suffered from a lack of standardization in evaluation, staging, assessment, end points, and response criteria. Recently defined criteria for the diagnosis of early MF, guidelines for initial evaluation, and revised staging and classification criteria for MF and SS now offer the potential for uniform staging of patients enrolled in clinical trials for MF/SS. This article presents consensus recommendations for the general conduct of clinical trials of patients with MF/SS as well as methods for standardized assessment of potential disease manifestations in skin, lymph nodes, blood, and visceral organs, and definition of end points and response criteria. These guidelines should facilitate collaboration among investigators and collation of data from sponsor-generated or investigator-initiated clinical trials involving patients with MF or SS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
Computed Tomography — An Increasing Source of Radiation Exposure
Brenner, D. J., & Hall, E. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra072149 · Cited by 8,748
Revised Response Criteria for Malignant Lymphoma
Cheson, B. D., Pfistner, B., Juweid, M. E., Gascoyne, R. D., Specht, L., Horning, S. J., Coiffier, B., Fisher, R. I., Hagenbeek, A., Zucca, E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2403 · Cited by 4,426
Self-citationWHO-EORTC classification for cutaneous lymphomas
Willemze, R. (2005) · Blood · doi:10.1182/blood-2004-09-3502 · Cited by 3,803
Self-citationCheson, B., Bennett, J., Grever, M., Kay, N., Keating, M., O'Brien, S., & Rai, K. (1996) · Blood · doi:10.1182/blood.v87.12.4990.bloodjournal87124990 · Cited by 1,819
Olsen, E., Vonderheid, E., Pimpinelli, N., Willemze, R., Kim, Y., Knobler, R., Zackheim, H., Duvic, M., Estrach, T., Lamberg, S., et al. (2007) · Blood · doi:10.1182/blood-2007-03-055749 · Cited by 1,429
Self-citationTreatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy
Edelson, R., Berger, C., Gasparro, F., Jegasothy, B., Heald, P., Wintroub, B., Vonderheid, E., Knobler, R., Wolff, K., Plewig, G., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702053160603 · Cited by 1,199
Self-citationOlsen, E. A., Kim, Y. H., Kuzel, T. M., Pacheco, T. R., Foss, F. M., Parker, S., Frankel, S. R., Chen, C., Ricker, J. L., Arduino, J. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.2434 · Cited by 1,055
Self-citationThiers, B. H. (2008) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)70989-4 · Cited by 974
Randomized versus historical controls for clinical trials
Sacks, H., Chalmers, T. C., & Smith, H. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90815-4 · Cited by 834
Chren, M.-M., Lasek, R. J., Quinn, L. M., Mostow, E. N., & Zyzanski, S. J. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12365600 · Cited by 699
Kim, Y. H., Liu, H. L., Mraz-Gernhard, S., Varghese, A., & Hoppe, R. T. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.7.857 · Cited by 653
Self-citationCutaneous T-Cell Lymphomas: The Sézary Syndrome, Mycosis Fungoides, and Related Disorders
LUTZNER, M., EDELSON, R., SCHEIN, P., GREEN, I., KIRKPATRICK, C., & AHMED, A. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-83-4-534 · Cited by 635
Olsen, E., Duvic, M., Frankel, A., Kim, Y., Martin, A., Vonderheid, E., Jegasothy, B., Wood, G., Gordon, M., Heald, P., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.376 · Cited by 609
Self-citationDefining early mycosis fungoides
Pimpinelli, N., Olsen, E. A., Santucci, M., Vonderheid, E., Haeffner, A. C., Stevens, S., Burg, G., Cerroni, L., Dreno, B., Glusac, E., et al. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.08.057 · Cited by 550
Self-citationVonderheid, E. C., Bernengo, M. G., Burg, G., Duvic, M., Heald, P., Laroche, L., Olsen, E., Pittelkow, M., Russell-Jones, R., Takigawa, M., et al. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.118538 · Cited by 493
Self-citationDuvic, M. A., Martín, Á. G., Kim, Y. H., Olsen, E. A., Wood, G. S., Crowley, C., & Yocum, R. C. (2001) · PubMed · Cited by 489
Self-citationChren, M.-M., Lasek, R. J., Sahay, A. P., & Sands, L. P. (2001) · Journal of Cutaneous Medicine and Surgery · doi:10.1007/bf02737863 · Cited by 450
Histopathologic Staging at Initial Diagnosis of Mycosis Fungoides and the Sézary Syndrome
Sausville, E. A., Eddy, J. L., Makuch, R. W., Fischmann, A. B., Schechter, G. P., Matthews, M., GLATSTEIN, E. J., Ihde, D. C., Kaye, F., Veach, S. R., et al. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-5-372 · Cited by 268
The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells
Bernengo, M. G., Novelli, M., Quaglino, P., Lisa, F., De Matteis, A., Savoia, P., Cappello, N., & Fierro, M. T. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04014.x · Cited by 201
Self-citationAbsence of CD26 Expression Is a Useful Marker for Diagnosis of T-Cell Lymphoma in Peripheral Blood
Jones, D., Dang, N. H., Duvic, M., Washington, L. T., & Huh, Y. O. (2001) · American Journal of Clinical Pathology · doi:10.1309/u1y6-j4ag-5m4m-7ayv · Cited by 201
Self-citationHarmon, C. B., Witzig, T. E., Katzmann, J. A., & Pittelkow, M. R. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90605-2 · Cited by 139
Self-citationQuantifying Skin Disease Burden in Mycosis Fungoides–Type Cutaneous T-Cell Lymphomas
Stevens, S. R., Ke, M. S., PARRY, E. J., Mark, J., & Cooper, K. D. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.1.42 · Cited by 101
Health-Related Quality-of-Life Assessment in Patients With Cutaneous T-Cell Lymphoma
Demierre, M., Tien, A., & Miller, D. R. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.3.325 · Cited by 97
Self-citationThe Sézary syndrome: hematologic criteria
Vonderheid, E. C., & Bernengo, M. G. (2003) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(03)00120-5 · Cited by 79
Self-citationCD4+CD7− T Cells: A Separate Subpopulation of Memory T Cells?
Reinhold, U., & Abken, H. (1997) · Journal of Clinical Immunology · doi:10.1023/a:1027318530127 · Cited by 60
Borowitz, M. J., Weidner, A., Olsen, E. A., & Picker, L. J. (1993) · PubMed · Cited by 55
Self-citationDummer, R., Nestle, F. O., Niederer, E. M., Ludwig, E., Laine, E., Grundmann, H., Grob, P. J., & Burg, G. (1999) · Archives of Dermatological Research · doi:10.1007/s004030050414 · Cited by 50
Self-citationExpression of Vβ Gene Segments by Sezary Cells
Gorochov, G., Bachelez, H., Cayuela, J., Legac, É., Laroche, L., Dubertret, L., & Sigaux, F. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12312560 · Cited by 41
Assessing Clinical Outcomes in Cutaneous T-cell Lymphoma
Zackheim, H. S., Koh, H. K., & Weinstock, M. A. (1995) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30056-x · Cited by 22
Cited by
Cheson, B. D., Fisher, R. I., Barrington, S. F., Cavalli, F., Schwartz, L. H., Zucca, E., & Lister, T. A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.8800 · Cited by 5,715
Padmanabhan, A., Connelly‐Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,230
Lesokhin, A. M., Ansell, S. M., Armand, P., Scott, E. C., Halwani, A., Gutierrez, M., Millenson, M. M., Cohen, A. D., Schuster, S. J., Lebovic, D., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.9789 · Cited by 1,001
Schwartz, J., Padmanabhan, A., Aqui, N., Balogun, R. A., Connelly‐Smith, L., Delaney, M., Dunbar, N. M., Witt, V., Wu, Y., & Shaz, B. H. (2016) · Journal of Clinical Apheresis · doi:10.1002/jca.21470 · Cited by 793
Connelly‐Smith, L., Alquist, C. R., Aqui, N. A., Hofmann, J. C., Klingel, R., Onwuemene, O. A., Patriquin, C. J., Pham, H. P., Sanchez, A. P., Schneiderman, J., et al. (2023) · Journal of Clinical Apheresis · doi:10.1002/jca.22043 · Cited by 684
Metadata
- Authors
- Olsen, E. A., Whittaker, S., Kim, Y. H., Duvic, M., Prince, H. M., Lessin, S. R., Wood, G. S., Willemze, R., Demierre, M.-F., Pimpinelli, N., Bernengo, M. G., Ortiz-Romero, P. L., Bagot, M., Estrach, T., Guitart, J., Knobler, R., Sanches, J. A., Iwatsuki, K., Sugaya, M., Dummer, R., Pittelkow, M., Hoppe, R., Parker, S., Geskin, L., Pinter-Brown, L., Girardi, M., Burg, G., Ranki, A., Vermeer, M., Horwitz, S., Heald, P., Rosen, S., Cerroni, L., Dreno, B., & Vonderheid, E. C.
- Venue
- Journal of Clinical Oncology
- Published
- 2011-06-20
- Volume
- 29
- Issue
- 18
- Pages
- 2598-2607
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2096850086
- Cited by
- 666
- References
- 30
- FWCI
- 39.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.